Q&A: Ronan Farrow on his Sam Altman profile in The New Yorker, how Altman changed in 18 months of reporting, OpenAI's board drama and enterprise shift, and more
Today on Decoder, I'm talking with Ronan Farrow, one of the biggest stars of investigative reporting working today.
Context & Ripple Effects
Farrow’s New Yorker profile follows years of coverage questioning Altman’s leadership and the unresolved governance conflict around his 2023 removal and return. The interview puts that reporting in conversation with OpenAI’s move toward enterprise customers, where leadership credibility and organizational control carry more commercial weight.
Earlier Altman interviews focused on explaining the board episode and OpenAI’s product and competitive roadmap. This coverage shifts attention toward how the company’s internal power structure and its chief executive’s reputation are interpreted by customers and partners.
First-order effects
- The New Yorker profile and Decoder discussion intensify scrutiny of Altman’s conduct and OpenAI’s governance at a point when the company is courting enterprise buyers.
- OpenAI’s leadership must address enterprise strategy alongside renewed questions about whether its board structure can effectively oversee its chief executive.
Second-order effects
- Enterprise customers and commercial partners are likely to treat governance clarity and leadership stability as part of their assessment of OpenAI, not as a separate internal matter.
- Competitors can position institutional reliability, controls, and predictable leadership as differentiators when selling AI systems to businesses.
Third-order effects
- If enterprise AI adoption continues to concentrate around a small number of model providers, governance disputes at those providers may increasingly become procurement and partnership risks.
- The episode points toward a market in which the economics of serving business AI workloads and the credibility of the organizations operating them become more tightly linked.
The trend: Generative-AI providers are evolving from research-led labs into enterprise infrastructure vendors, making governance and executive trust part of their commercial proposition.